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a b s t r a c t 
The dataset presented herein is related to a previous re- 
search article titled “Mitochondrial Complex III in Larval 
Stage of Echinococcus multilocularis as a Potential Chemother- 
apeutic Target and in vivo Efficacy of Atovaquone Against Pri- 
mary Hydatid Cysts” [1] . In this report, data were collected 
by screening drugs for echinococcosis. We investigated the 
inhibitory activities of artemisinin and pyrvinium pamoate 
against the mitochondrial respiratory enzymes in E. multi- 
locularis protoscoleces. Artemisinin did not inhibit mitochon- 
drial complexes I, II, and III. However, pyrvinium pamoate 
inhibited complex I at 11 μM, although complexes II and 
III were not inhibited. In the culture assay, E. multilocularis 
protoscoleces were treated with atovaquone (ATV), rotenone, 
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praziquantel, artemisinin, and pyrvinium pamoate at a fi- 
nal concentration of 50 μM in different culture media. The 
viability of protoscoleces was compared under aerobic and 
anaerobic conditions via culture experiments. The survival 
days of E. multilocularis protoscoleces were evaluated in the 
drug-treated group compared with those in the non-treated 
group. The results of these culture assays revealed that praz- 
iquantel and artemisinin did not eliminate the protoscole- 
ces under both aerobic and anaerobic conditions. However, 
a stronger elimination ability was observed with the co- 
administration of praziquantel or artemisinin with ATV than 
with ATV alone under aerobic conditions. Pyrvinium pamoate 
completely killed protoscoleces at 5 and 7 days under aerobic 
and anaerobic conditions, respectively. Pyrvinium pamoate 
behaved identically to rotenone, the complex I inhibitor, in 
the culture treatment assay. The data serve as a reference for 
the development of novel anti-echinococcal drugs. 
© 2020 The Authors. Published by Elsevier Inc. 
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Subject Drug Discovery 
Specific subject area Mitochondrial respiratory system 
Type of data Figure and table 
How data were acquired IC 50 of artemisinin and pyrvinium pamoate against the mitochondrial respiratory 
enzymes, and culture treatment assay using E. multilocularis protoscoleces 
Data format Raw 
Analyzed 
Parameters for data collection IC 50 of artemisinin and pyrvinium pamoate against the mitochondrial respiratory 
enzymes in E. multilocularis protoscoleces was measured. The viability of 
protoscoleces was compared under aerobic and anaerobic conditions in culture 
experiments. Survival rate and days of E. multilocularis protoscoleces were 
evaluated in the drug-treated and non-treated groups. 
Description of data collection Inhibitory activities of artemisinin and pyrvinium pamoate against the 
mitochondrial respiratory enzymes were determined using a spectrophotometer 
(SHIMADZU UV-30 0 0, Kyoto, Japan). In the culture, E. multilocularis protoscoleces 
were treated with atovaquone, rotenone, praziquantel, artemisinin, and pyrvinium 
pamoate at a final concentration of 50 μM in each culture medium. The viability 
of protoscoleces was determined by microscopic analysis of more than 170 
protoscoleces per well for the ability to exclude trypan blue. 
Data source location Institution: Hokkaido Institute of Public Health 
City: Sapporo 
Country: Japan 
Latitude and longitude (and GPS coordinates) for collected samples/data: 
43 °04 ′ 58.804 ′ ’N; 141 ° 19 ′ 59.769 ′ ’E. 
Data accessibility With the article 
Related research article S. Enkai, D.K. Inaoka, H. Kouguchi, T. Irie, K. Yagi, K. Kita, Mitochondrial complex 
III in larval stage of Echinococcus multilocularis as a potential chemotherapeutic 
target and in vivo efficacy of atovaquone against primary hydatid cysts, Parasitol. 
Int. 75 (2019) 102004. https://doi.org/10.1016/j.parint.2019.102004 
alue of the Data 
• The data provide the inhibitory activity of artemisinin and pyrvinium pamoate against the
mitochondrial respiratory chain of E. multilocularis . Artemisinin did not inhibit mitochondrial














complexes I, II, and III in E. multilocularis protoscoleces. Pyrvinium pamoate inhibited the
mitochondrial complex I activity of E. multilocularis protoscoleces at IC 50 11.3 μM. 
• The data describe the efficacy of the combination of atovaquone with praziquantel or
artemisinin against E. multilocularis protoscoleces in culture assays. The combined administra-
tion shortened the duration of parasite elimination compared with atovaquone alone under
the aerobic conditions, but had no effect under anaerobic conditions. 
• In culture experiments, pyrvinium pamoate, which inhibited mitochondrial complex I, com-
pletely eliminated E. multilocularis protoscoleces at 6 and 7 days under aerobic and anaerobic
condition, respectively. 
1. Data Description 
The data in Table 1 show that pyrvinium pamoate inhibited mitochondrial complex I at IC 50 
11.3 μM but did not inhibit complexes II and III (IC 50 > 30 μM). Artemisinin did not block
mitochondrial complexes I, II, and III (IC 50 > 40 μM). Fig. 1 shows the anti-parasitic effect of
50 μM atovaquone (ATV), rotenone, praziquantel, artemisinin, pyrvinium pamoate, and com-
bination chemotherapy of ATV and other drugs in a culture experiment using E. multilocularis
protoscoleces. Praziquantel and artemisinin did not eliminate E. multilocularis protoscoleces un-
der both aerobic and anaerobic conditions. Interestingly, under aerobic conditions, a stronger
elimination ability was observed with the co-administration of praziquantel or artemisinin withTable 1 
The inhibitory effect of pyrvinium pamoate and artemisinin for the mitochondrial respiratory chain of E.multilocularis 
protoscoleces. 







(Complex I) (Complex II) (Complex II and III) 
Pyrvinium pamoate 11 ± 0.3 > 30 > 30 
Artemisinin > 40 > 40 > 40 
Fig. 1. Culture under aerobic and anaerobic conditions (O2 < 0.3%); E. multilocularis protoscoleces were treated with 
atovaquone, rotenone, praziquantel, artemisinin, and pyrvinium pamoate at a final concentration of 50 μM in each cul- 
ture medium. The viability of protoscoleces was evaluated as their ability to exclude trypan blue. The data are presented 
as mean and standard deviation of triplicate samples. Rotenone was added as a positive control for drug treatment as 
previously reported [1,2] . The raw data tables are available as supplementary material. 












































TV than with ATV alone. Pyrvinium pamoate killed all protoscoleces at 6 days under aerobic
onditions and 95 % at 7 days under anaerobic conditions. 
. Experimental Design, Materials and Methods 
.1. Preparation of the mitochondrial fraction from E. multilocularis protoscoleces 
All experiments were performed as described previously [1] . The infected cotton rats ( Sig-
odon hispidus) were sacrificed by isoflurane overdose to obtain the cyst tissues containing
. multilocularis (Nemuro strain) protoscoleces. The tissues were passed through a metal mesh
nd shredded completely. Thereafter, the tissues were repeatedly suspended and washed in a tall
eaker to isolate protoscoleces using the difference in buoyancy between the protoscoleces and
ther tissue [1,2] . The parasite materials were homogenized with a motor-driven homogenizer
o prepare the mitochondrial fraction of E. multilocularis protoscoleces, while icing them. The
omogenate was diluted with the mitochondrial preparation buffer (210 mM mannitol, 10 mM
ucrose, 1 mM disodium EDTA, and 50 mM Tris-HCl; pH 7.5) supplemented with 10 mM sodium
alonate to five times the volume of the original protoscolex sediment, and then centrifuged at
00 × g for 10 min (4 °C) to remove cell debris and nuclei. The supernatant was then centrifuged
t 8,0 0 0 × g for 10 min (4 °C) to obtain the mitochondrial pellet. The pellet was re-suspended
n mitochondrial preparation buffer (without malonate) and centrifuged at 8,0 0 0 × g for 10 min
4 °C). The enriched mitochondrial fraction was suspended in mitochondrial preparation buffer
ithout malonate. 
.2. Enzyme assays and 50% inhibitory concentration (IC50) determination 
All enzyme assays using mitochondrial fractions were performed in 0.5 or 1 mL reaction
ixtures at 25 °C using an absorption spectrophotometer. Before the assay, the mitochondrial
uspension was thawed at room temperature and refrozen in a deep freezer. The refrozen sam-
le was thawed again after 1 h. This freezing and thawing process was performed before the
ssay to ensure that the mitochondrial membrane was permeable to the solutes. Without this
rocess, NADH cannot pass through the mitochondrial membrane as a substrate. The reagents
sed in each assay were mixed with the reaction buffer (30 mM potassium phosphate and
 mM MgCl 2 , pH 7.5). The final mitochondrial protein concentration was 50 μg/mL. NADH-decyl
hodoquinone reductase activity (complex I), succinate quinone reductase activity (complex II),
nd succinate-cytochrome c reductase activity (complexes II and III) were measured using a SHI-
ADZU spectrophotometer UV-30 0 0 (Kyoto, Japan) as described previously [1,2] . The IC 50 values
f pyrvinium pamoate and artemisinin were determined by calculating approximation lines from
hree or more points of anteroposterior concentration to the IC 50 values. 
.3. Culture treatment of E. multilocularis protoscoleces 
The metacestodes from one cotton rat at 4 months after infection with 50 eggs were full of
ature protoscoleces and were enough to perform the culture experiment. Praziquantel alone
annot inhibit the mitochondrial respiratory system [3] . However, praziquantel can exert its ef-
ects in synergy with albendazole, although synergy with ATV has not been demonstrated [4] .
he complementary culture experiment based on our previous report was performed to deter-
ine the efficacy of the combination therapy of ATV with praziquantel or artemisinin. Addition-
lly, the efficacy of pyrvinium pamoate, which inhibited complex I of E. multilocularis , was ascer-
ained in a culture assay under aerobic and anaerobic conditions. In this experiment, rotenone
as used as the control to compare with previous report findings [1,2] . 






























The obtained protoscoleces were cultured in Connaught Medical Research Laboratories
10 6 6 medium (Gibco, Grand Island, NY, USA) containing 23 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid, 0.5% (w/v) D ( + )-glucose, 0.4 mM sodium taurocholate (Wako
Pure Chemical Industries), 0.5% (w/v) yeast extract (Difco Laboratories, Detroit, MI, USA), 57 mM
sodium hydrogen carbonate, 2 mM L-glutamine (Gibco), 100 U/mL penicillin, and 100 μg/mL
streptomycin (Gibco). Half of the medium was replaced on day 3. For anaerobic cultures, six-well
plates were sealed in plastic containers with oxygen-detecting agents and oxygen scavengers
(Aneromeito®, Nissui Pharmaceutical, Tokyo, Japan) to maintain the oxygen concentration under
0.3% at 37 °C. To assess the effect of chemical compounds against E. multilocularis protoscoleces,
the parasites were treated with rotenone, praziquantel, artemisinin, pyrvinium pamoate, and
ATV at a final concentration of 50 μM in the culture medium. The control group was supple-
mented with 0.5% (v/v) dimethyl sulfoxide (DMSO), and all conditions were assayed in triplicate.
The viability of protoscoleces was determined by microscopic observation of more than 170 pro-
toscoleces per well using the trypan blue exclusion test. The protoscoleces were observed daily
for 7 consequent days, and the efficacy of the treatment was evaluated by the duration of para-
site elimination based on previous reports [1,2,5,6] . 
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